These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 26782254)
1. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial. Kim CW; Baek JH; Choi GS; Yu CS; Kang SB; Park WC; Lee BH; Kim HR; Oh JH; Kim JH; Jeong SY; Ahn JB; Baik SH Trials; 2016 Jan; 17():34. PubMed ID: 26782254 [TBL] [Abstract][Full Text] [Related]
2. GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study. Cotte E; Villeneuve L; Passot G; Boschetti G; Bin-Dorel S; Francois Y; Glehen O; BMC Cancer; 2015 Feb; 15():47. PubMed ID: 25849254 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis. Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581 [TBL] [Abstract][Full Text] [Related]
4. The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic, Synchronous, Unresectable Metastasis: A Multicenter Randomized Controlled Trial. Park EJ; Baek JH; Choi GS; Park WC; Yu CS; Kang SB; Min BS; Kim JH; Kim HR; Lee BH; Oh JH; Jeong SY; Jung M; Ahn JB; Baik SH Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824392 [TBL] [Abstract][Full Text] [Related]
5. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases. Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502 [TBL] [Abstract][Full Text] [Related]
6. Impact of resection versus no resection of the primary tumor on survival in patients with colorectal cancer and synchronous unresectable metastases: protocol for a randomized multicenter study (CR4). Biondo S; Frago R; Kreisler E; Espin-Basany E; Int J Colorectal Dis; 2017 Jul; 32(7):1085-1090. PubMed ID: 28497402 [TBL] [Abstract][Full Text] [Related]
7. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group. van der Kruijssen DEW; Elias SG; van de Ven PM; van Rooijen KL; Lam-Boer J'; Mol L; Punt CJA; Sommeijer DW; Tanis PJ; Nielsen JD; Yilmaz MK; van Riel JMGH; Wasowiz-Kemps DK; Loosveld OJL; van der Schelling GP; de Groot JWB; van Westreenen HL; Jakobsen HL; Fromm AL; Hamberg P; Verseveld M; Jaensch C; Liposits GI; van Duijvendijk P; Oulad Hadj J; van der Hoeven JAB; Trajkovic M; de Wilt JHW; Koopman M; Ann Oncol; 2024 Sep; 35(9):769-779. PubMed ID: 38852675 [TBL] [Abstract][Full Text] [Related]
8. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial. Kanemitsu Y; Shitara K; Mizusawa J; Hamaguchi T; Shida D; Komori K; Ikeda S; Ojima H; Ike H; Shiomi A; Watanabe J; Takii Y; Yamaguchi T; Katsumata K; Ito M; Okuda J; Hyakudomi R; Shimada Y; Katayama H; Fukuda H; J Clin Oncol; 2021 Apr; 39(10):1098-1107. PubMed ID: 33560877 [TBL] [Abstract][Full Text] [Related]
9. Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial. van der Kruijssen DEW; Elias SG; Vink GR; van Rooijen KL; 't Lam-Boer J; Mol L; Punt CJA; de Wilt JHW; Koopman M; JAMA Surg; 2021 Dec; 156(12):1093-1101. PubMed ID: 34613339 [TBL] [Abstract][Full Text] [Related]
10. Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor. Cetin B; Kaplan MA; Berk V; Tufan G; Benekli M; Isikdogan A; Ozkan M; Coskun U; Buyukberber S Jpn J Clin Oncol; 2013 Jan; 43(1):28-32. PubMed ID: 23107836 [TBL] [Abstract][Full Text] [Related]
11. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor. Matsumoto T; Hasegawa S; Matsumoto S; Horimatsu T; Okoshi K; Yamada M; Kawada K; Sakai Y Dis Colon Rectum; 2014 Jun; 57(6):679-86. PubMed ID: 24807591 [TBL] [Abstract][Full Text] [Related]
12. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cirocchi R; Trastulli S; Abraha I; Vettoretto N; Boselli C; Montedori A; Parisi A; Noya G; Platell C Cochrane Database Syst Rev; 2012 Aug; (8):CD008997. PubMed ID: 22895981 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database. van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases. Yun JA; Park Y; Huh JW; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK J Surg Oncol; 2014 Dec; 110(7):839-44. PubMed ID: 25043872 [TBL] [Abstract][Full Text] [Related]
15. The impact of primary tumor resection for asymptomatic colorectal cancer patients with unresectable metastases: a systematic review and meta-analysis. Li S; Ji L; Huang J; Wang Y; Liu P; Zhang W; Lou Z Int J Colorectal Dis; 2023 Aug; 38(1):214. PubMed ID: 37581775 [TBL] [Abstract][Full Text] [Related]
16. Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials. Rahbari NN; Biondo S; Frago R; Feißt M; Kreisler E; Rossion I; Serrano M; Jäger D; Lehmann M; Sommer F; Dignass A; Bolling C; Vogel I; Bork U; Büchler MW; Folprecht G; Kieser M; Lordick F; Weitz J; J Clin Oncol; 2024 May; 42(13):1531-1541. PubMed ID: 38412408 [TBL] [Abstract][Full Text] [Related]
17. Surgery of the primary in stage IV colorectal cancer with unresectable metastases. Verhoef C; de Wilt JH; Burger JW; Verheul HM; Koopman M Eur J Cancer; 2011 Sep; 47 Suppl 3():S61-6. PubMed ID: 21944031 [TBL] [Abstract][Full Text] [Related]
18. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. Bennouna J; Sastre J; Arnold D; Österlund P; Greil R; Van Cutsem E; von Moos R; Viéitez JM; Bouché O; Borg C; Steffens CC; Alonso-Orduña V; Schlichting C; Reyes-Rivera I; Bendahmane B; André T; Kubicka S; Lancet Oncol; 2013 Jan; 14(1):29-37. PubMed ID: 23168366 [TBL] [Abstract][Full Text] [Related]
19. Aspects of survival from colorectal cancer in Denmark. Iversen LH Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726 [TBL] [Abstract][Full Text] [Related]
20. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Scoggins CR; Meszoely IM; Blanke CD; Beauchamp RD; Leach SD Ann Surg Oncol; 1999; 6(7):651-7. PubMed ID: 10560850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]